🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Abris mulls sale of Polish healthcare company Scanmed -sources

Published 11/17/2023, 11:22 AM
Updated 11/17/2023, 05:35 PM
© Reuters.

By Anna Koper

WARSAW (Reuters) -Abris Capital Partners investment fund is mulling a sale of private healthcare provider Scanmed Group, with Polish cardiovascular care company American Heart of Poland being the most likely buyer, sources familiar with the process told Reuters.

The Polish private healthcare sector is attracting investors as Poles' expenditures on health are growing rapidly. In 2022, expenditures on private healthcare grew by over 10% to almost 52 billion zlotys ($12.94 billion).

"Abris is preparing to put Scanmed on sale with American Heart of Poland being the most obvious buyer," one source told Reuters on condition of anonymity.

Another source confirmed the information, adding the company could be valued even at 350 million euros ($380.63 million). A third person said Abris expects a very high valuation without giving a specific figure.

Abris bought Scanmed in 2020 from Life Healthcare Group Holdings with the company valued at 340 million zlotys.

If the deal goes through, it will be another example of a merger in the Polish private healthcare sector after Italy's Gruppo San Donato agreed to buy a majority stake in American Heart of Poland, valuing the company at more than 500 million euros($544.35 million).

Abris declined to comment, while American Heart of Poland described itself as "an entity actively consolidating the medical care market in Poland".

"As part of our strategic options, we consider organic growth opportunities as well as mergers and acquisitions. We are currently analysing all development opportunities that may increase the group's potential," it said in an e-mailed statement.

Scanmed runs medical and cardiology centres as well as three multi-specialist hospitals in almost 40 locations across Poland.

The group had a net loss of 13.9 million zlotys on revenue of 615.6 million zlotys in the 15 months ended on December 2022, compared to a net loss of 12.3 million zlotys and 410.5 million zlotys in revenue in the 12 months ended in September 2021.

($1 = 4.0199 zlotys)

($1 = 0.9195 euros)

(Reportin by Anna Koper; Editing by Bill Berkrot and Cynthia Osterman)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.